Neuronetics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Neuronetics, Inc. (STIM) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $2.01 per share as of 2020-12-31, per its 10-K filed 2023-03-07.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2023-03-07
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.01.
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.01.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.94.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $2.94.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2020-12-31 | $2.01 10-K · filed 2023-03-07 |
| 2020-09-30 | $2.01 10-Q · filed 2020-11-02 |
| 2020-06-30 | $2.94 10-Q · filed 2020-08-04 |
| 2020-03-31 | $2.94 10-Q · filed 2020-05-05 |
| 2019-12-31 | $14.27 10-K · filed 2022-03-08 |
| 2019-09-30 | $14.82 10-Q · filed 2019-11-05 |
| 2019-06-30 | $16.08 10-Q · filed 2019-08-06 |
| 2019-03-31 | $16.49 10-Q · filed 2019-05-07 |
| 2018-12-31 | $8.41 10-K · filed 2021-03-02 |
| 2017-12-31 | $2.90 10-K · filed 2020-03-03 |
| 2016-12-31 | $2.32 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |